Cargando…
Low heritability in pharmacokinetics of talinolol: a pharmacogenetic twin study on the heritability of the pharmacokinetics of talinolol, a putative probe drug of MDR1 and other membrane transporters
BACKGROUND: Efflux transporters like MDR1 and MRP2 may modulate the pharmacokinetics of about 50 % of all drugs. It is currently unknown how much of the variation in the activities of important drug membrane transporters like MDR1 or MRP2 is determined by genetic or by environmental factors. In this...
Autores principales: | Matthaei, Johannes, Tzvetkov, Mladen V., Gal, Valerie, Sachse-Seeboth, Cordula, Sehrt, Daniel, Hjelmborg, Jakob B., Hofmann, Ute, Schwab, Matthias, Kerb, Reinhold, Brockmöller, Jürgen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5101708/ https://www.ncbi.nlm.nih.gov/pubmed/27825374 http://dx.doi.org/10.1186/s13073-016-0372-2 |
Ejemplares similares
-
Inherited and Acquired Determinants of Hepatic CYP3A Activity in Humans
por: Matthaei, Johannes, et al.
Publicado: (2020) -
Analysis of Complex Absorption After Multiple Dosing: Application to the Interaction Between the P-glycoprotein Substrate Talinolol and Rifampicin
por: Weiss, Michael, et al.
Publicado: (2022) -
Evaluation of Self-Nanoemulsifying Drug Delivery Systems (SNEDDS) for Poorly Water-Soluble Talinolol: Preparation, in vitro and in vivo Assessment
por: Kazi, Mohsin, et al.
Publicado: (2019) -
Pharmacogenetics: data, concepts and tools to improve drug discovery and drug treatment
por: Brockmöller, Jürgen, et al.
Publicado: (2008) -
Effects of Genetic Polymorphism in CYP2D6, CYP2C19, and the Organic Cation Transporter OCT1 on Amitriptyline Pharmacokinetics in Healthy Volunteers and Depressive Disorder Patients
por: Matthaei, Johannes, et al.
Publicado: (2021)